## 4 Discussion  
There was an improvement in MAS in both groups at the 10 th and 30 th day evaluations, in comparison with the evaluation performed on the first day, but when comparing the indexes from the last day of therapy (10 th), with the indexes from the 30 th day after treatment, we observed an increase in the values. Our results show that, within four weeks, the MAS values are not as low as they were on the last day of therapy. The Barthel Scores improve on the last day of the therapy (10 th day) and on the 30 th day after treatment, in comparison with the first day of the therapy in both groups. However, it decreases significantly when comparing the value on the 10 th day of therapy with the value on the 30 th day after treatment in the control group, and without statistical significance in the study group, which means that the improvements in ADL are more persistent in the study group. When comparing the two groups, the differences between MAS values between the 1 st and the 10 th day, and between the 1 st and the 30 th day, were more significant in the study group, which means that the 9 min protocol (with one extra minute of electromagnetic stimulation on the agonist muscles) had a better outcome. However, the differences in MAS values between the 10 th and the 30 th day did not achieve statistical significance when comparing the two groups, which means that the effects on spasticity of both protocols are attenuated in a 4 weeks' time in the same manner. Moreover, the percent of improved cases (from day 1 to day 10 of treatment, and from day 1 to day 30 after the completion of therapy) was statistically significantly higher in the study group, but there was no difference between groups when comparing the percentage of improved cases from the 10 th day to the 30 th day after the completion of therapy. Even if, in the study group, in more than 50% (68,97%) of participants, MAS values improved or remained unchanged until the 30 th day, in the control group, in more than 50% (51.61%) of cases, MAS values worsened, and we did not achieve statistical significance (\(p=0.087\)). The reduction in MAS values 30 days after the discontinuation of treatment could be explained by the lack of continuity or neglect of adequate physical therapy at home by patients and/or the lack of daily monitoring of patients with decreased motivation and compliance with treatment. Patients and their families and caregivers should be adequately trained in physical therapy at home, as well as in the possibility of using virtual therapy and telerehabilitation. Telerehabilitation allows long-term treatment to be provided to \begin{table}
\begin{tabular}{c c c c c} \hline \hline  & **Status** & **Study Group (\(n=29\))** & **Control Group (\(n=31\))** & \(p\) \\ \hline \multirow{3}{*}{Status MAS Day 1-Day 10, no (\%)} & improved & 29 (100) & 21 (67.74) & \multirow{3}{*}{**0.004**} \\  & unchanged & 0 (0) & 10 (32.26) & \\ \cline{3-5}  & worsened & 0 (0) & 0 (0) & \\ \cline{3-5}  & improved & 23 (79.31) & 6 (19.35) & \\ \cline{3-5}  & unchanged & 6 (20.69) & 25 (80.65) & **\textless{0.001**}** \\ \cline{3-5}  & worsened & 0 (0) & 0 (0) & \\ \cline{3-5}  & improved & 1 (3.45) & 0 (0) & \\ \cline{3-5}  & unchanged & 19 (65.52) & 15 (48.39) & 0.087 \\ \cline{3-5}  & worsened & 9 (31.03) & 16 (51.61) & \\ \cline{3-5}  & improved & 27 (93.1) & 30 (96.77) & \\ \cline{3-5}  & unchanged & 2 (6.9) & 1 (3.23) & 1 \\ \cline{3-5}  & worsened & 0 (0) & 0 (0) & \\ \cline{3-5}  & improved & 23 (79.31) & 29 (93.55) & \\ \cline{3-5}  & unchanged & 5 (17.24) & 2 (6.45) & 0.744 \\ \cline{3-5}  & worsened & 1 (3.45) & 0 (0) & \\ \cline{3-5}  & improved & 4 (13.79) & 3 (9.68) & \\ \cline{3-5}  & unchanged & 13 (44.83) & 14 (45.16) & 0.554 \\ \cline{3-5}  & worsened & 12 (41.38) & 14 (45.16) & \\ \hline \hline \end{tabular} \(p\) obtained with Mann–Whitney test.  
\end{table} 
Table 3: Status analysis: improved, unchanged, or worsened between the moments of testing.